Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Lapke

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Vaccine|November 25, 2015
The application of anti-Toso antibody enhances CD8(+) T cell responses in experimental malaria vaccination and diseaseNina Lapke, Susanne Tartz, Kyeong-Hee Lee, et al.
Case Reports in Oncological Medicine|March 20, 2020
Advanced Lung Adenocarcinoma Patient with <i>ERBB2</i> Amplification Identified by Comprehensive Genomic Profiling Benefits from TrastuzumabChi-Wei Tao, Mei-Yin Chen, Ching-Min Tseng, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2017
Pazopanib Sensitivity in a Patient With Breast Cancer and <i>FGFR1</i> AmplificationFiona Tsui-Fen Cheng, Fu Ou-Yang, Nina Lapke, et al.
Oncotarget|June 11, 2016
Missense mutations in the TP53 DNA-binding domain predict outcomes in patients with advanced oral cavity squamous cell carcinomaNina Lapke, Yen-Jung Lu, Chun-Ta Liao, et al.
Case Reports in Oncological Medicine|October 5, 2019
Liquid Biopsy Detects Relapse Five Months Earlier than Regular Clinical Follow-Up and Guides Targeted Treatment in Breast CancerFiona Tsui-Fen Cheng, Nina Lapke, Chin-Chu Wu, et al.
BMC Cancer|May 5, 2021
Genetic alterations and their therapeutic implications in epithelial ovarian cancerNina Lapke, Chien-Hung Chen, Ting-Chang Chang, et al.
Cancers|August 2, 2019
<i>TP53</i> DNA Binding Domain Mutations Predict Progression-Free Survival of Bevacizumab Therapy in Metastatic Colorectal CancerHung-Chih Hsu, Jeng-Fu You, Shu-Jen Chen, et al.
Cancers|September 12, 2018
Hung-Chih Hsu, Nina Lapke, Shu-Jen Chen, et al.
Oncotarget|December 2, 2016
Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancerAngel Chao, Ting-Chang Chang, Nina Lapke, et al.
Molecular Cancer Therapeutics|July 13, 2018
Targeted Sequencing of Circulating Tumor DNA to Monitor Genetic Variants and Therapeutic Response in Metastatic Colorectal CancerHung-Chih Hsu, Nina Lapke, Chuang-Wei Wang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Vaccine|November 25, 2015
The application of anti-Toso antibody enhances CD8(+) T cell responses in experimental malaria vaccination and diseaseNina Lapke, Susanne Tartz, Kyeong-Hee Lee, et al.
Case Reports in Oncological Medicine|March 20, 2020
Advanced Lung Adenocarcinoma Patient with <i>ERBB2</i> Amplification Identified by Comprehensive Genomic Profiling Benefits from TrastuzumabChi-Wei Tao, Mei-Yin Chen, Ching-Min Tseng, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2017
Pazopanib Sensitivity in a Patient With Breast Cancer and <i>FGFR1</i> AmplificationFiona Tsui-Fen Cheng, Fu Ou-Yang, Nina Lapke, et al.
Oncotarget|June 11, 2016
Missense mutations in the TP53 DNA-binding domain predict outcomes in patients with advanced oral cavity squamous cell carcinomaNina Lapke, Yen-Jung Lu, Chun-Ta Liao, et al.
Case Reports in Oncological Medicine|October 5, 2019
Liquid Biopsy Detects Relapse Five Months Earlier than Regular Clinical Follow-Up and Guides Targeted Treatment in Breast CancerFiona Tsui-Fen Cheng, Nina Lapke, Chin-Chu Wu, et al.
BMC Cancer|May 5, 2021
Genetic alterations and their therapeutic implications in epithelial ovarian cancerNina Lapke, Chien-Hung Chen, Ting-Chang Chang, et al.
Cancers|August 2, 2019
<i>TP53</i> DNA Binding Domain Mutations Predict Progression-Free Survival of Bevacizumab Therapy in Metastatic Colorectal CancerHung-Chih Hsu, Jeng-Fu You, Shu-Jen Chen, et al.
Cancers|September 12, 2018
Hung-Chih Hsu, Nina Lapke, Shu-Jen Chen, et al.
Oncotarget|December 2, 2016
Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancerAngel Chao, Ting-Chang Chang, Nina Lapke, et al.
Molecular Cancer Therapeutics|July 13, 2018
Targeted Sequencing of Circulating Tumor DNA to Monitor Genetic Variants and Therapeutic Response in Metastatic Colorectal CancerHung-Chih Hsu, Nina Lapke, Chuang-Wei Wang, et al.
Pageof 1